US2015208682A1PendingUtilityA1

Enzyme preparations yielding a clean taste

Assignee: DSM IP ASSETS BVPriority: Nov 28, 2005Filed: Apr 10, 2015Published: Jul 30, 2015
Est. expiryNov 28, 2025(expired)· nominal 20-yr term from priority
C12N 9/18C12Y 301/06001C12N 9/62C12Y 302/01108C12N 9/2402C12N 9/2468A23C 9/127A23C 19/0328C12N 9/50C12Y 302/01023C12P 21/00C12N 9/2471A23C 9/1206A23L 5/25C12N 9/16
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention describes a intracellular produced lactase, which comprises less than 40 units arylsulfatase activity per NLU of lactase activity. The invention also provides a process comprising treating a substrate with an enzyme preparation, wherein the enzyme preparation is substantially free from arylsulfatase.

Claims

exact text as granted — not AI-modified
1 . A process for producing a dairy product which comprises adding a lactase obtained from yeast to a dairy product comprising lactose, wherein said lactase comprises less than 30 units arylsulfatase activity per NLU of lactase activity. 
     
     
         2 . The process of  claim 1  wherein the dairy product produced is free of off-flavours produced by arylsulfatase. 
     
     
         3 . The process according to  claim 2 , wherein said dairy product contains an alkyl phenol substituted with a sulfate group. 
     
     
         4 . The process according to  claim 2 , wherein the dairy product contains milk protein. 
     
     
         5 . The process according to  claim 2 , wherein the dairy product is selected from the group consisting of milk and a fermented milk product. 
     
     
         6 . The process according to  claim 2 , wherein the level of arylsulfatase in the dairy product during said treating is at most 500*10E3 arylsulfatase units per liter of dairy product. 
     
     
         7 . A dairy product obtainable by the process according to  claim 2 . 
     
     
         8 . The process according to  claim 4 , wherein the milk protein is selected from the group consisting of casein and whey protein. 
     
     
         9 . The process according to  claim 5 , wherein the fermented milk product is yoghurt, whey or a hydrolysate. 
     
     
         10 . The process according to  claim 6 , wherein the level of arylsulfatase in the dairy product during said treating is at most 250*10E3 arylsulfatase units per liter of dairy product. 
     
     
         11 . The process according to  claim 10 , wherein the level of arylsulfatase in the dairy product during said treating is at most 100*10E3 arylsulfatase units per liter of dairy product. 
     
     
         12 . The process according to  claim 10 , wherein the level of arylsulfatase in the dairy product during said treating is at most 50*10E3 arylsulfatase units per liter of dairy product. 
     
     
         13 . The process according to  claim 10 , wherein the level of arylsulfatase in the dairy product during said treating is at most 25*10E3 arylsulfatase units per liter of dairy product. 
     
     
         14 . The process of  claim 2  wherein said lactase is obtained by:
 (a) separation of arylsulfatase using chromatography from a preparation which comprises lactase and arylsulfatase, 
 (b) cultivating a lactase expressing cell in growth medium to which sulphate has been added to repress arylsulfatase expression, 
 (c) using a lactase expressing cell in which the gene for arylsulfatase is eliminated or disrupted; or 
 (d) using a lactase expressing strain having less than 10% of the detectable intracellular or extracellular arylsulfatase activity of the wild type strain from which the lactase expressing strain originates. 
 
     
     
         15 . The process according to  claim 14 , wherein said lactase is neutral lactase. 
     
     
         16 . The process according to  claim 14 , wherein said lactase is neutral lactase from  Kluyveromyces lactis.    
     
     
         17 . The process according to  claim 14 , wherein said lactase is a neutral lactase derived from the cytoplasm of yeast. 
     
     
         18 . The process according to  claim 14 , wherein said off flavor is medicinal. 
     
     
         19 . The process according to  claim 14 , wherein said lactase expressing strain has less than 5% of the detectable intracellular or extracellular arylsulfatase activity of the wild type strain from which the lactase expressing strain originates. 
     
     
         20 . The process according to  claim 14 , wherein said lactase expressing strain has less than 1% of the detectable intracellular or extracellular arylsulfatase activity of the wild type strain from which the lactase expressing strain originates. 
     
     
         21 . The process according to  claim 14 , wherein arylsulfatase activity is undetectable in said lactase expressing strain. 
     
     
         22 . The process of  claim 1  wherein the yeast is  Kluyveromyces.    
     
     
         23 . The process of  claim 22  wherein the yeast is  Kluyveromyces lactis.    
     
     
         24 . The process according to  claim 14 (c), wherein the gene disruption is achieved by a method selected from one-step gene disruption, marker insertion, site directed mutagenesis, deletion, RNA interference, or anti-sense RNA. 
     
     
         25 . The process according to  claim 14 (c), wherein the lactase expressing cell in which the gene for arylsulfatase is eliminated or disrupted produces more lactase than the wild type cell under the same culture conditions. 
     
     
         26 . Lactase which comprises less than 30 units arylsulfatase activity per NLU of lactase activity. 
     
     
         27 . Dairy product comprising lactase of  claim 26 . 
     
     
         28 . Process to purify a lactase containing enzyme preparation which comprises separation of aryl-sulfatase from lactase using chromotagraphy. 
     
     
         29 . Process comprising treating a substrate with an enzyme preparation, wherein the enzyme preparation is substantially free from arylsulfatase. 
     
     
         30 . Process for preparing an enzyme preparation, said process comprising purifying a crude enzyme preparation which contains an enzyme of interest and arylsulfatase, wherein arylsulfatase is separated from the enzyme of interest. 
     
     
         31 . Process to produce a host cell which is an arylsulfatase deficient strain, which comprises bringing a culture which produces arylsulfatase under conditions that part of the culture is modified to form the host cell which is arylsulfatase deficient and isolating the host cell. 
     
     
         32 . A process to produce a polypeptide by a method comprising:
 (a) cultivating an arylsulfatase deficient host cell in a nutrient medium, under conditions conductive to expression of the polypeptide   (b) expressing the polypeptide in said host cell, and   (c) optionally recovering the polypeptide from the nutrient medium or from the host cell.   
     
     
         33 . Enzyme preparation comprising a lactase, which enzyme preparation comprises less than 30 units arylsulfatase activity per NLU of lactase activity.

Join the waitlist — get patent alerts

Track US2015208682A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.